Clinical trial
A Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome
NCT07276568 is registered in ClinicalTrials.gov with Zhi-Jun Zhu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome
- Lead sponsor
- Zhi-Jun Zhu
- Phase
- Phase 1
- Overall status
- Enrolling by invitation
- Start date
- December 17, 2025
- Completion date
- December 1, 2029
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
small-for-size syndrome